$2.2 million raised to build VR tools for amblyopia
Treatment for binocular vision disorders is available at more than 90 clinics across the world.
Colin Kerr
Published: Tuesday, May 23, 2017
[caption id="attachment_8371" align="alignnone" width="800"]
Image Credit: Vivid Vision[/caption]
Medical technology company Vivid Vision has announced that it has raised $2.2 million to build Virtual Reality (VR) tools that could be used to treat amblyopia.
The company says its VR treatment for binocular vision disorders is available at more than 90 clinics across the world.
Founded in 2014, Vivid Vision applies virtual reality to the field of vision care. Its founder and CEO, James Blaha, a programmer and lifelong sufferer of amblyopia, started the company after experimenting on himself. Before building the first prototype, Blaha couldn’t read with his weak eye or see in 3D.
Since then, according to Vivid Vision, the vision in Blaha’s weak eye has improved to nearly 20/20. Vivid Vision launched its clinical vision therapy suite in late 2015 for optometrists and ophthalmologists and since then, the 90 clinics using it have treated more than 6,000 patients. On average, treatment lasts eight months, with patients coming one or two times a week to use the VR system.
www.seevividly.com
“It is a unique, far more efficient solution to treat Amblyopia, as well as a wide array of binocular vision dysfunction,” said Dan Fortenbacher, founder of Wow Vision Therapy, which has two locations in Michigan. “The progress the patient makes in breaking through suppression and developing 3D vision has been remarkable with Vivid Vision.”
Image Credit: Vivid Vision[/caption]
Medical technology company Vivid Vision has announced that it has raised $2.2 million to build Virtual Reality (VR) tools that could be used to treat amblyopia.
The company says its VR treatment for binocular vision disorders is available at more than 90 clinics across the world.
Founded in 2014, Vivid Vision applies virtual reality to the field of vision care. Its founder and CEO, James Blaha, a programmer and lifelong sufferer of amblyopia, started the company after experimenting on himself. Before building the first prototype, Blaha couldn’t read with his weak eye or see in 3D.
Since then, according to Vivid Vision, the vision in Blaha’s weak eye has improved to nearly 20/20. Vivid Vision launched its clinical vision therapy suite in late 2015 for optometrists and ophthalmologists and since then, the 90 clinics using it have treated more than 6,000 patients. On average, treatment lasts eight months, with patients coming one or two times a week to use the VR system.
www.seevividly.com
“It is a unique, far more efficient solution to treat Amblyopia, as well as a wide array of binocular vision dysfunction,” said Dan Fortenbacher, founder of Wow Vision Therapy, which has two locations in Michigan. “The progress the patient makes in breaking through suppression and developing 3D vision has been remarkable with Vivid Vision.”
Tags: amblyopia
Latest Articles
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Update on Astigmatism Analysis
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
How Many Surgeries Equal Surgical Proficiency?
Internet, labs, simulators, and assisting surgery all contribute.